Search research articles
Contact Us
Filters
Showing results (681-690 of 763) with videos related to
Page
of 77
Sort By:
Science (New York, N.Y.)
|
March 24, 2007
Restoration of the Mississippi Delta: lessons from Hurricanes Katrina and Rita
John W Day, Donald F Boesch, Ellis J Clairain, et al.
Organic & Biomolecular Chemistry
|
June 27, 2019
The cubane paradigm in bioactive molecule discovery: further scope, limitations and the cyclooctatetraene complement
Sevan D Houston, Tyler Fahrenhorst-Jones, Hui Xing, et al.
Biological Psychiatry
|
September 15, 2020
Dysregulated Lipid Metabolism Precedes Onset of Psychosis
Alex M Dickens, Partho Sen, Matthew J Kempton, et al.
Nature Medicine
|
July 9, 2026
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial
G Paul, H Bjartmarz, A Kirkeby, et al.
Early Intervention in Psychiatry
|
January 7, 2026
Feasibility of a Stepped-Care Intervention for Those at Clinical High Risk for Psychosis in the United States
Daniel I Shapiro, Rebecca E Grattan, Jill R Laquidara, et al.
The Australian and New Zealand Journal of Psychiatry
|
August 26, 2025
Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO study
Monika Schlögelhofer, Ashleigh Lin, Connie Markulev, et al.
Journal of the American Heart Association
|
May 21, 2013
Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart
Shiraj Sen, Bijoy K Kundu, Henry Cheng-Ju Wu, et al.
Trials
|
November 6, 2014
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial
Christopher G Davey, Andrew M Chanen, Sue M Cotton, et al.
JAMA Psychiatry
|
November 29, 2016
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial
Patrick D McGorry, Barnaby Nelson, Connie Markulev, et al.
Brain Communications
|
November 8, 2021
Dissection of <i>TAF1</i> neuronal splicing and implications for neurodegeneration in X-linked dystonia-parkinsonism
Simona Capponi, Nadja Stöffler, Ellen B Penney, et al.
Page
of 77
Search research articles
Search
Showing results (681-690 of 763) with videos related to
Sort By:
Page
of 77
Science (New York, N.Y.)
|
March 24, 2007
Restoration of the Mississippi Delta: lessons from Hurricanes Katrina and Rita
John W Day, Donald F Boesch, Ellis J Clairain, et al.
Organic & Biomolecular Chemistry
|
June 27, 2019
The cubane paradigm in bioactive molecule discovery: further scope, limitations and the cyclooctatetraene complement
Sevan D Houston, Tyler Fahrenhorst-Jones, Hui Xing, et al.
Biological Psychiatry
|
September 15, 2020
Dysregulated Lipid Metabolism Precedes Onset of Psychosis
Alex M Dickens, Partho Sen, Matthew J Kempton, et al.
Nature Medicine
|
July 9, 2026
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial
G Paul, H Bjartmarz, A Kirkeby, et al.
Early Intervention in Psychiatry
|
January 7, 2026
Feasibility of a Stepped-Care Intervention for Those at Clinical High Risk for Psychosis in the United States
Daniel I Shapiro, Rebecca E Grattan, Jill R Laquidara, et al.
The Australian and New Zealand Journal of Psychiatry
|
August 26, 2025
Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO study
Monika Schlögelhofer, Ashleigh Lin, Connie Markulev, et al.
Journal of the American Heart Association
|
May 21, 2013
Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart
Shiraj Sen, Bijoy K Kundu, Henry Cheng-Ju Wu, et al.
Trials
|
November 6, 2014
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial
Christopher G Davey, Andrew M Chanen, Sue M Cotton, et al.
JAMA Psychiatry
|
November 29, 2016
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial
Patrick D McGorry, Barnaby Nelson, Connie Markulev, et al.
Brain Communications
|
November 8, 2021
Dissection of <i>TAF1</i> neuronal splicing and implications for neurodegeneration in X-linked dystonia-parkinsonism
Simona Capponi, Nadja Stöffler, Ellen B Penney, et al.
Page
of 77